Page last updated: 2024-08-21

oxazoles and u 100480

oxazoles has been researched along with u 100480 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Barbachyn, MR; Brickner, SJ; Cynamon, MH; Ford, CW; Glickman, SE; Grega, KC; Hendges, SK; Hutchinson, DK; Kilburn, JO; Klemens, SP; Toops, DS; Zurenko, GE1
Artico, M; Deidda, D; Lampis, G; Mai, A; Massa, S; Pompei, R; Sbardella, G1
Duncan, K1
Chase, S; Cynamon, MH; Klemens, SP; Sharpe, CA1
Chang, KC; Heyckendorf, J; Lange, C; Olaru, ID; von Groote-Bidlingmaier, F; Yew, WW1
Betoudji, F; Converse, PJ; Dartois, V; Li, SY; Mdluli, KE; Mendel, CM; Nuermberger, EL; Tasneen, R; Tyagi, S; Williams, K; Yang, T1
Causgrove, C; Dartois, V; Drusano, GL; Flynn, JL; Graham, E; Kim, S; Louie, A; Miranda Silva, C; Peloquin, CA; Scanga, CA; Schmidt, S; Stein, B; Zimmerman, M1

Reviews

2 review(s) available for oxazoles and u 100480

ArticleYear
The impact of genomics on the search for novel tuberculosis drugs.
    Novartis Foundation symposium, 1998, Volume: 217

    Topics: Acetamides; Antitubercular Agents; Drug Design; Genome, Bacterial; Mycobacterium tuberculosis; Ofloxacin; Oxazoles; Rifamycins

1998
Novel drugs against tuberculosis: a clinician's perspective.
    The European respiratory journal, 2015, Volume: 45, Issue:4

    Topics: Adamantane; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarylquinolines; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Male; Nitroimidazoles; Oxazoles; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2015

Other Studies

5 other study(ies) available for oxazoles and u 100480

ArticleYear
Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity.
    Journal of medicinal chemistry, 1996, Feb-02, Volume: 39, Issue:3

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Oxazoles; Rats

1996
N-[4-(1,1'-biphenyl)methyl]-4-(4-thiomorpholinylmethyl) benzenamines as non-oxazolidinone analogues of antimycobacterial U-100480.
    Bioorganic & medicinal chemistry letters, 1998, Jun-16, Volume: 8, Issue:12

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium; Oxazoles; Species Specificity; Vero Cells

1998
Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:5

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Antitubercular Agents; Female; Linezolid; Mice; Mycobacterium tuberculosis; Oxazoles; Oxazolidinones; Tuberculosis

1999
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Animals; Antitubercular Agents; Bacterial Load; Diarylquinolines; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Linezolid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Organophosphates; Oxazoles; Oxazolidinones; Pyrazinamide; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary

2016
Pharmacokinetics of tedizolid, sutezolid, and sutezolid-M1 in non-human primates.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2020, Aug-01, Volume: 151

    Topics: Animals; Anti-Bacterial Agents; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Oxazolidinones; Primates; Tetrazoles

2020